We’ve recently updated our valuation analysis.

Viva Biotech Holdings Valuation

Is VBIZ.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VBIZ.F?

Other financial metrics that can be useful for relative valuation.

VBIZ.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.3x
Enterprise Value/EBITDA14.4x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does VBIZ.F's PE Ratio compare to its peers?

The above table shows the PE ratio for VBIZ.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11.3x
MRVI Maravai LifeSciences Holdings
7.4x-34.0%US$3.5b
BIOQ Bioqual
12.4xn/aUS$65.3m
SHC Sotera Health
14.1x33.8%US$1.7b
SYNH Syneos Health
10.7x-6.0%US$3.1b
VBIZ.F Viva Biotech Holdings
24.5xn/aUS$3.0b

Price-To-Earnings vs Peers: VBIZ.F is expensive based on its Price-To-Earnings Ratio (24.5x) compared to the peer average (11.3x).


Price to Earnings Ratio vs Industry

How does VBIZ.F's PE Ratio compare vs other companies in the US Life Sciences Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a13.3%
n/an/an/a

Price-To-Earnings vs Industry: VBIZ.F is good value based on its Price-To-Earnings Ratio (24.5x) compared to the US Life Sciences industry average (26.4x)


Price to Earnings Ratio vs Fair Ratio

What is VBIZ.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VBIZ.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate VBIZ.F's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of VBIZ.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate VBIZ.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate VBIZ.F's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies